United Therapeutics (UTHR) Misses Q4 EPS by 8c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $510.38 -0.99%
Financial Fact:
Income tax expense: -77.3M
Today's EPS Names:
RIBT, INLB, FTXP, More
Financial Fact:
Income tax expense: -77.3M
Today's EPS Names:
RIBT, INLB, FTXP, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $4.36, $0.08 worse than the analyst estimate of $4.44. Revenue for the quarter came in at $614.7 million versus the consensus estimate of $575.1 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Exclusive: Axe Compute CEO says prepayments cover about a third of $3bn build cost
- UBS Downgrades JINS Holdings Inc (3046:JP) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
